4.0 Article

Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation

期刊

出版社

SPRINGER
DOI: 10.1007/s10840-012-9690-5

关键词

Catheter ablation; Atrial fibrillation; Radiofrequency ablation; Stroke

资金

  1. Biosense Webster, Inc.
  2. Sanofi-Aventis
  3. Biosense Webster, Inc., Diamond Bar, CA

向作者/读者索取更多资源

Catheter ablation for atrial fibrillation (AF) has been demonstrated to be safe and effective in subsets of patients with AF, but primarily in patients age < 65. This study compared acute safety in patients age a parts per thousand yen65 vs. those < 65 who have undergone catheter ablation for AF. A retrospective analysis of data from two Thomson Reuters MarketScanA (R) research databases was performed on 5,947 patients who underwent catheter ablation for treatment of AF. Acute safety was measured as a composite endpoint of procedure-related adverse events coded a parts per thousand currency sign7 days post-procedure. A logistic regression model was fitted to this endpoint, using age (< 65, a parts per thousand yen65) and relevant covariates. Peri-procedural mortality rates were examined among patients with inpatient ablation procedures, where death rates could be determined by discharge status. The acute safety event rate was nearly identical between both groups. This finding persisted after adjusting for covariates in the logistic regression model (p = 0.6648). There were no peri-procedural mortalities among the 3,575 index ablation procedures performed in an inpatient setting. Acute safety of catheter ablation for AF in patients a parts per thousand yen65 was consistent with that of younger patients. A prior history of hypertension and stroke was associated with a high risk for complications with AF ablation. These findings in a large, real world population may have implications for Medicare patients with AF.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据